---

John Aunins

Executive Vice President and Chief Technology Officer, Seres Health, USA

“During 2006, the team I was part of at Merck licensed four new vaccines addressing infectious diseases that pose significant public health threats and did not otherwise have a preventative strategy,” says John. “I hope to leverage this experience at Seres to develop novel biologics to treat diseases by targeting dysbiosis of the microbiome.”

http://sereshealth.com

---

Part of the Power List 2015

Who are the most influential medicine makers?

That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2015